Maelstrom Research Staging | SIC_Underlying_medical_conditions_Adverse_event

SIC_Underlying_medical_conditions_Adverse_event_recurrences

Networks -

Variables -

Population

SIC – Underlying medical conditions

The population is composed of patients with underlying medical conditions who are hypersensitive to a component of a COVID-19 vaccine and require a pre-vaccination assessment.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Halifax, Quebec City, Montreal, Sherbrooke, Ottawa, Toronto, Hamilton, Saskatoon, Edmonton, Calgary, Vancouver

Ethnic Origin

Health Status

Patients with underlying medical conditions who are hypersensitive to a component of a COVID-19 vaccine and require a pre-vaccination assessment

Other Criteria

Patients with vaccine hesitancy or concerns will be excluded from the study.

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

Participants are referred to the study by a healthcare provider (physician, nurse practitioner, public health physician).

Number of Participants

Number of Participants
Number of Participants with Biological Samples

More info

Data Collection Event

SIC - Underlying medical conditions - Adverse event recurrences

Information was or will be collected about the reoccurrence of adverse events following immunization (AEFIs) in the population and the relative severity of the recurrent AEFI compared to the initial AEFI.

More info

Collected Dataset / SIC_Underlying_medical_conditions_Adverse_event_recurrences

SIC_Underlying_medical_conditions_Adverse_event_recurrences

Population

SIC – Underlying medical conditions

Data Collection Event

SIC - Underlying medical conditions - Adverse event recurrences

Files

Variables Classifications